Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30421% above fair value
$22.11−1.42 (-6.03%)
Close on Nov 18, 2026Market cap $3.43BP/E –Yield –
Zai Lab revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Zai Lab's revenue for the twelve months ending Jun 30, 2026 was $449.61M, up 5.1% year over year. For fiscal 2025 it was $460.16M, up 15.3% from the year before. The highest annual figure on record is $460.16M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $460.16M | +15.3% |
| FY2024 | Dec 31, 2024 | $398.99M | +49.6% |
| FY2023 | Dec 31, 2023 | $266.72M | +24.0% |
| FY2022 | Dec 31, 2022 | $215.04M | +49.0% |
| FY2021 | Dec 31, 2021 | $144.31M | +194.8% |
| FY2020 | Dec 31, 2020 | $48.96M | +277.0% |
| FY2019 | Dec 31, 2019 | $12.99M | +9965.9% |
| FY2018 | Dec 31, 2018 | $129.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $106.31M | -3.3% |
| Q1 FY2026 | Mar 31, 2026 | $99.61M | -6.5% |
| Q4 FY2025 | Dec 31, 2025 | $127.60M | +17.0% |
| Q3 FY2025 | Sep 30, 2025 | $116.10M | +13.5% |
| Q2 FY2025 | Jun 30, 2025 | $109.98M | +9.4% |
| Q1 FY2025 | Mar 31, 2025 | $106.49M | +22.2% |
| Q4 FY2024 | Dec 31, 2024 | $109.07M | +65.7% |
| Q3 FY2024 | Sep 30, 2024 | $102.27M | +47.7% |
| Q2 FY2024 | Jun 30, 2024 | $100.50M | +45.9% |
| Q1 FY2024 | Mar 31, 2024 | $87.15M | +38.8% |
| Q4 FY2023 | Dec 31, 2023 | $65.83M | +5.2% |
| Q3 FY2023 | Sep 30, 2023 | $69.23M | +20.3% |
| Q2 FY2023 | Jun 30, 2023 | $68.86M | +42.9% |
| Q1 FY2023 | Mar 31, 2023 | $62.80M | +34.4% |
| Q4 FY2022 | Dec 31, 2022 | $62.60M | +42.4% |
| Q3 FY2022 | Sep 30, 2022 | $57.54M | +33.5% |
| Q2 FY2022 | Jun 30, 2022 | $48.18M | +30.4% |
| Q1 FY2022 | Mar 31, 2022 | $46.72M | +132.4% |
| Q4 FY2021 | Dec 31, 2021 | $43.96M | +191.3% |
| Q3 FY2021 | Sep 30, 2021 | $43.10M | +194.2% |
| Q2 FY2021 | Jun 30, 2021 | $36.94M | +235.9% |
| Q1 FY2021 | Mar 31, 2021 | $20.10M | +144.6% |
| Q4 FY2020 | Dec 31, 2020 | $15.09M | +224.9% |
| Q3 FY2020 | Sep 30, 2020 | $14.65M | +197.8% |
| Q2 FY2020 | Jun 30, 2020 | $11.00M | – |
| Q1 FY2020 | Mar 31, 2020 | $8.22M | – |
| Q4 FY2019 | Dec 31, 2019 | $4.65M | – |
| Q3 FY2019 | Sep 30, 2019 | $4.92M | – |
See a number that looks wrong?